Physician profile
Evlyn Avanessian
NPI 1295020709
$2,512.23
in general payments reported to CMS, 2019-2025
18 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $82.52 · 2021: $42.61 · 2022: $730 · 2023: $232 · 2024: $457 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.83 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $517.02 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.16 | 2020-2024 | Jardiance |
| Amgen INC. | $224.09 | 2023-2025 | Otezla |
| Allergan, INC. | $198.44 | 2022 | |
| Phathom Pharmaceuticals, INC. | $169.33 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.34 | 2019 | |
| Abiomed | $138.49 | 2019 | |
| Abbvie INC. | $129.73 | 2023 | Creon |
| Esperion Therapeutics, INC. | $124.26 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.01 | 2019 | |
| Glaxosmithkline, LLC. | $107.19 | 2019-2020 | |
| Intuitive Surgical, INC. | $103.18 | 2024 | |
| Pulmonx Corporation | $79.38 | 2024 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Coloplast Corp | $71.27 | 2022 | |
| Janssen Pharmaceuticals, INC | $46.07 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.81 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $22.19 | 2022 | |
| Hologic INC | $20.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evlyn Avanessian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.